Latest Earnings Analysis

• Scholar Rock (SRRK) Q3 2025: $142M Capital Infusion Extends Runway as SMA Launch Hinges on Facility Remediation
  November 14, 2025 · SRRK
• T1 Energy (TE) Q3 2025: G1 Dallas Hits 5.2 GW Run Rate, Catalyzing Integrated U.S. Solar Push
  November 14, 2025 · TE
• MSC Income Fund (MSIF) Q3 2025: Private Loan Portfolio Hits 60% of Investments as M&A Pipeline Accelerates
  November 14, 2025 · MSIF
• Ecopetrol (EC) Q3 2025: Capex Hits 72% of Plan as Energy Transition and Cost Discipline Drive Resilience
  November 14, 2025 · EC
• Aerojoule (AIRJ) Q3 2025: Water Purchase Agreement Pipeline Expands Across Dozens of Industrial Prospects
  November 14, 2025 · AIRJ
• EZPW Q4 2025: Jewelry PLO Hits 68%, Unlocking Margin and Digital Leverage
  November 14, 2025 · EZPW
• Iterum Therapeutics (ITRM) Q3 2025: Orlimba Coverage Hits 16% of Insured Lives, Commercial Reach Expands
  November 14, 2025 · ITRM
• Teleflex (TFX) Q3 2025: Interventional Revenue Jumps 76%, Reshaping Growth Mix Amid NuCo Sale Progress
  November 14, 2025 · TFX
• VolitionRx (VNRX) Q3 2025: Operating Expenses Down 10% as Licensing Pipeline Accelerates
  November 14, 2025 · VNRX
• Broadridge (BR) Q1 2026: Tokenization Adds $4M Recurring Revenue, Accelerating Digital Asset Strategy
  November 14, 2025 · BR
• Mink Therapeutics (INKT) Q3 2025: 700% Equity Surge Fuels Pipeline Expansion in INKT Cell Therapy
  November 14, 2025 · INKT
• Southland (SLND) Q3 2025: Core Civil Margins Hold at 10.5% as Legacy Drag Nears End
  November 14, 2025 · SLND
• US Global Investors (GROW) Q1 2026: Shareholder Yield Rises to 8.3% as Gold and Resources Rebound
  November 14, 2025 · GROW
• CuriosityStream (CURI) Q3 2025: Licensing Revenue Surges 425% as AI Content Demand Accelerates
  November 14, 2025 · CURI
• SKYX Q3 2025: Gross Margin Climbs to 32% as B2B Pipeline and AI Platform Expand
  November 14, 2025 · SKYX
• BitDigital (BTBT) Q3 2025: ETH Holdings Surge 5x, Staking Revenue Jumps 542% as Model Shifts
  November 14, 2025 · BTBT
• Stantec (STN) Q3 2025: $8.4B Backlog Signals 15% Demand Surge, Margin Expansion Ahead
  November 14, 2025 · STN
• NetPower (NPWR) Q3 2025: $425M Permian Project Accelerates Clean Gas Power Pivot
  November 14, 2025 · NPWR
• Spire (SR) Q4 2025: EPS Guidance Jumps 20% on Missouri Rate Win, Tennessee Acquisition in Focus
  November 14, 2025 · SR
• Twist Bioscience (TWST) Q4 2025: AI-Driven Orders Add $25M, Pushing DNA Synthesis Momentum
  November 14, 2025 · TWST
• P3 Health (PIII) Q3 2025: $100M EBITDA Improvement Anchors Path to 2026 Profitability
  November 14, 2025 · PIII
• Arrow (AIRO) Q3 2025: $200M Booking Pipeline Anchors Defense Drone Expansion
  November 14, 2025 · AIRO
• RLX (RLX) Q3 2025: International Revenue Jumps to 80% of Mix as Europe, APAC Drive Margin Expansion
  November 14, 2025 · RLX
• KEPCO (KEP) Q3 2025: Fuel Costs Drop 16% as Nuclear Mix Rises, Margin Outlook Shifts
  November 14, 2025 · KEP
• Alpha Cognition (ACOG) Q3 2025: Zunvale Demand Bottles Double, 70% Repeat Orders Signal Deepening LTC Penetration
  November 14, 2025 · ACOG
• Precision Optics (POCI) Q1 2026: Aerospace Backlog Tops $9M, Anchoring Multiyear Production Ramp
  November 14, 2025 · POCI
• Tamborin Resources (TBN) Q1 2026: $160M Funding Secured as Beetaloo Pilot Reaches 68% Completion
  November 14, 2025 · TBN
• Luminar (LAZR) Q4 2025: LSI Photonics Grows to One-Third of Revenue as Automotive Uncertainty Deepens
  November 14, 2025 · LAZR
• ICG (ICG) Q3 2025: 42% Inventory Impairment Drives Margin Strain as Altcoin Cycle Shifts
  November 14, 2025 · ICG
• SERA Q3 2025: Medicaid Pilot Prepayment Hits $100K as State Expansion Drives Commercial Traction
  November 14, 2025 · SERA
• InVenture (INV) Q3 2025: Excelsius Pipeline Surges 79% as Production Orders Accelerate
  November 14, 2025 · INV
• FitLife Brands (FTLF) Q3 2025: Wholesale Revenue Jumps 156% on Erwin Naturals Acquisition, Margin Pressures Build
  November 14, 2025 · FTLF
• Trisalis Life Sciences (TLSI) Q3 2025: Mapping Drives 30% of Growth as TriNav Platform Broadens Clinical Reach
  November 14, 2025 · TLSI
• Telebio (TELA) Q3 2025: Salesforce Expands to 76 Territory Managers, Driving Foundation for 15%+ Growth
  November 14, 2025 · TELA
• Fluent (FLNT) Q3 2025: Commerce Media Solutions Jumps to 40% of Revenue, Reshaping Growth Mix
  November 14, 2025 · FLNT
• Legacy Education (LGCY) Q1 2026: Enrollment Climbs 31.6%, Margin Expansion Set as New Programs Launch
  November 14, 2025 · LGCY
• Evolve Technology (EVLV) Q3 2025: 57% Revenue Surge Masks 25% ARR Pivot as Model Shifts to Recurring
  November 14, 2025 · EVLV
• WidePoint (WYY) Q3 2025: $45M SaaS Win Anchors FedRAMP Growth, Backlog Exceeds $269M
  November 14, 2025 · WYY
• Jefferson Capital (JCAP) Q3 2025: Collections Jump 63% as Bluestem Deal Extends Runway
  November 14, 2025 · JCAP
• Omeros (OMER) Q3 2025: $2.1B Novo Nordisk Deal Reshapes Capital and Pipeline Trajectory
  November 14, 2025 · OMER
• Vistagen (VTGN) Q2 2026: Palisade 3 Completes Enrollment of 236, Setting Stage for Pivotal Data Readout
  November 14, 2025 · VTGN
• Glimpse Group (VRAR) Q1 2026: Brightline IPO Spin-Off Targeted as Revenue Drops 43%
  November 14, 2025 · VRAR
• Owlet (OWLT) Q3 2025: International Revenue Jumps 171% as Regulatory Moat Widens
  November 14, 2025 · OWLT
• Pioneer Power (PPSI) Q3 2025: Distributed Power Orders Top $1.4M, Accelerating Market Diversification
  November 14, 2025 · PPSI
• Profound Medical (PROF) Q3 2025: Tulsa Pro Revenue Jumps 87% as BPH AI Launch Expands TAM
  November 14, 2025 · PROF
• 10X Therapeutics (TENX) Q3 2025: Phase 3 Oral TNX-103 Transition Yields 7m Additional Six-Minute Walk Gain
  November 14, 2025 · TENX
• PGEN Q3 2025: Pepsimus Launch Engages 90% of Target Centers, Igniting Rare Disease Uptake Cycle
  November 14, 2025 · PGEN
• Trevi Therapeutics (TRVI) Q3 2025: $115M Raise Extends Runway, Phase 3 Cough Trials Set for 2026
  November 14, 2025 · TRVI
• DARE (DARE) Q3 2025: R&D Expenses Drop 56% as Dual Path Strategy Targets Near-Term Revenue
  November 14, 2025 · DARE
• Research Solutions (RSSS) Q1 2026: B2B ARR Jumps 21% as Platform Margins Expand to 88%
  November 14, 2025 · RSSS